Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis

Clinical and Experimental Metastasis

Volumn 32, Issue 4, 2015, Pages 383-391

  Subira D ^a   Simo M ^b   Illan J ^c   Serrano, C ^d   Castanon S ^d   Gonzalo, R ^d   Granizo, J J ^e   Martinez Garcia M ^f   Navarro, M ^g   Pardo, J ^h   Bruna, J ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Unilabs   (France)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e HOSPITAL INFANTA CRISTINA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h HOSPITAL UNIVERSITARIO REY JUAN CARLOS   (Spain)

Author keywords

Cerebrospinal fluid; Diagnosis; Flow cytometry; Immunophenotype; Leptomeningeal disease; Prognosis

Indexed keywords

CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN;

AGED; BIOSYNTHESIS; CELL COUNT; CEREBROSPINAL FLUID; CYTOLOGY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; VALIDATION STUDY;

AGED; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL COUNT; CEREBROSPINAL FLUID; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; PROGNOSIS;

EID: 84930910286     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-015-9716-3     Document Type: Article

References (35)

1. Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5:443–452
2. Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22:627–635. doi:10.1097/CCO.0b013e32833de986
3. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Vrionis FD, Wen PY, National Comprehensive Cancer Network (2011) Central nervous system cancers. J Natl Compr Cancer Netw 9:352–400
4. Bruna J, Simó M, Velasco R (2012) Leptomeningeal metastases. Curr Treat Options Neurol 14:402–415
5. Strik H, Prömmel P (2010) Diagnosis and individualized therapy of neoplastic meningitis. Expert Rev Anticancer Ther 10:1137–1148
6. Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert MR, Weinberg J, Cristofanilli M, Yung WKA, Liu TJ (2009) Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol 94:229–234
7. Herrlinger U, Wiendl H, Renninger M, Förschler H, Dichgans J, Weller M (2004) Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. Br J Cancer 91:219–224
8. Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 105:496–502
9. Subirá D, Górgolas M, Castañón S, Serrano C, Román A, Rivas F, Tomás JF (2005) Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin’s lymphoma in AIDS patients. HIV Med 6:21–26
10. Benevolo G, Stacchini A, Spina M, Ferreri AJ, Arras M, Bellio L, Botto B, Bulian P, Cantonetti M, Depaoli L, Di Renzo N, Di Rocco A, Evangelista A, Franceschetti S, Godio L, Mannelli F, Pavone V, Pioltelli P, Vitolo U, Pogliani EM, Linfomi Fondazione Italiana (2012) Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. Blood 120:3222–3228. doi:10.1182/blood-2012-04-423095 Epub 2012 Aug 27
11. Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM, Spanish Group for the Study of CNS Disease in NHL (2010) Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab era. Eur J Haematol 85:321–328. doi:10.1111/j.1600-0609.2010.01478.x Epub 2010 Jul 28
12. Alvarez R, Dupuis J, Plonquet A, Christov C, Copie-Bergman C, Hemery F, Gaillard I, El Gnaoui T, Kuhnowski F, Bedoui M, Belhadj K, Brugières P, Haioun C (2012) Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma. Ann Oncol 23:1274–1279
13. Wilson WH, Bromberg JE, Stetler-Stevenson M, Steinberg SM, Martin-Martin L, Muñiz C, Sancho JM, Caballero MD, Davidis MA, Brooimans RA, Sanchez-Gonzalez B, Salar A, González-Barca E, Ribera JM, Shovlin M, Filie A, Dunleavy K, Mehrling T, Spina M, Orfao A (2014) Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica 99:1228–1235
14. Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, Martínez-García M, Millastre E, Aparisi F, Navarro M, Dómine M, Gil-Bazo I, Pérez Segura P, Gil M, Bruna J (2012) Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis. NeuroOncol 14:43–52
15. de Jongste AH, Kraan J, Broek PD, Brooimans RA, Bromberg JE, Montfort KA, Smitt PA, Gratama JW (2014) Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage. Cytom B Clin Cytom 86:272–279
16. Subirá D, Castañón S, Aceituno E, Hernández J, Jiménez-Garófano C, Jiménez A, Jiménez AM, Román A, Orfao A (2002) Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice. Am J Clin Pathol 117:952–958
17. Bruna J, González L, Miró J, Velasco R, Gil M, Tortosa A (2009) Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features. Cancer 115:381–389. doi:10.1002/cncr.24041
18. Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375
19. Chang A, Benda PM, Wood BL, Kussick SJ (2003) Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol 119:643–655
20. Pillai V, Cibas ES, Dorfman DM (2013) A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Am J Clin Pathol 139:672–681. doi:10.1309/AJCP4HIFSHMO9WTK
21. Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007) Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications. Diagn Cytopathol 35:568–578
22. Kentrou NA, Tsagarakis NJ, Tzanetou K, Damala M, Papadimitriou KA, Skoumi D, Stratigaki A, Anagnostopoulos NI, Malamou-Lada E, Athanassiadou P, Paterakis G (2011) An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Cytom B Clin Cytom 80:324–334. doi:10.1002/cyto.b.20608 Epub 2011 Jun 21
23. Krishan A, Ganjei-Azar P, Hamelik R, Sharma D, Reis I, Nadji M (2010) Flow immunocytochemistry of marker expression in cells from body cavity fluids. Cytom A 77:132–143. doi:10.1002/cyto.a.20824
24. Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000) Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. J Clin Pathol 53:513–517. doi:10.1136/jcp.53.7.513
25. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS (2011) Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2:752–760
26. Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Reiner A, Liu CM, Deangelis LM, Omuro A (2013) Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology 80:1598–1605. doi:10.1212/WNL.0b013e31828f183f Epub 2013 Apr 3
27. Songun I, Litvinov SV, van de Velde CJ, Pals ST, Hermans J, van Krieken JH (2005) Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92:1767–1772
28. Klymkowsky MW, Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am J Pathol 174:1588–1593. doi:10.2353/ajpath.2009.080545
29. Chamberlain MC, Johnston SK, Glantz MJ (2009) Neoplastic meningitis-related prognostic significance of the Karnofsky performance status. Arch Neurol 66:74–78
30. Oechsle K, Lange-Brock V, Kruell A, Bokemeyer C, de Wit M (2010) Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol 136:1729–1735. doi:10.1007/s00432-010-0831-x Epub 2010 Mar 4
31. de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, de Azevedo Pereira AE, Fanelli MF, Gimenes DL (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neurooncol 104:565–572. doi:10.1007/s11060-010-0524-y Epub 2011 Jan 14
32. Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, Laurence V, Livartowski A, Mignot L, Dieras V (2010) Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21:2183–2187
33. Chamberlain MC, Johnston SK (2009) Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology. Cancer 115:1941–1946. doi:10.1002/cncr.24210
34. Muñiz C, Martín-Martín L, López A, Sánchez-González B, Salar A, Almeida J, Sancho JM, Ribera JM, Heras C, Peñalver FJ, Gómez M, González-Barca E, Alonso N, Navarro B, Olave T, Sala F, Conde E, Márquez JA, Cabezudo E, Cladera A, García-Malo M, Caballero MD, Orfao A, Spanish Group for the Study of Central Nervous System Disease in Non-Hodgkin Lymphoma (2014) Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome. Blood 123:1864–1869. doi:10.1182/blood-2013-11-537993 Epub 2014 Feb 5
35. Illán J, Simo M, Serrano C, Castañón S, Gonzalo R, Martínez-García M, Pardo J, Gómez L, Navarro M, Pérez Altozano J, Álvarez R, Bruna J, Subirá D (2014) Differences in the cerebrospinal fluid inflammatory cell reaction of patients with leptomeningeal involvement by lymphoma and carcinoma. Transl Res 164:460–467. doi:10.1016/j.trsl.2014.03.012